ADIM
ASPN icon

Alpha DNA Investment Management’s Aspen Aerogels ASPN Stock Holding History

Alpha DNA Investment Management’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-36,860
Closed -$438K – 25
2024
Q4 		$438K Buy
+36,860
New +$628K 0.17% 143
2024
Q3 		– Sell
-16,686
Closed -$398K – 201
2024
Q2 		$398K Buy
+16,686
New +$392K 0.15% 168

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpha DNA Investment Management's ASPN Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 36,860 shares — an estimated $438K sold.

Alpha DNA Investment Management first reported a position in ASPN in Q2 2024 and held it in 2 quarters. The position peaked at $438K in Q4 2024. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 36,860 Aspen Aerogels shares in Q1 2025, an estimated $438K.
  • Alpha DNA Investment Management first reported a position in Aspen Aerogels in Q2 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's Aspen Aerogels position peaked at $438K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.